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(57) ABSTRACT 
Compounds for use in a rechargeable battery are provided, 
including a compound according to the formula: 
wherein R1 and R9 are independently selected from the 
group consisting of H, alkyl, aryl, perfluoroaryl, perfluoro-
alkyl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, 
haloalkyl, perfluoroalkyl, glycols, haloaryl, a negative elec-
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and R10 is selected from the group consisting of methyl, 
alkyl, aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbo-
nyl, haloalkyl, perfluoroalkyl, perfluoroaryl, glycols, 
haloaryl, an oligomer, and a polymer. 
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1,9,10-SUBSTITUTED PHENOTHIAZINE 
DERIVATIVES WITH STRAINED RADICAL 
CATIONS AND USE THEREOF 
PRIORITY 
This invention claims priority to U.S. Provisional Appli-
cation Ser. No. 62/364,060 filed Jul. 19, 2016. 
GOVERNMENT INTEREST 
This invention was made with govermnent support under 
grant number 1300653 awarded by the National Science 
Foundation. The govermnent has certain rights in the inven-
tion. 
TECHNICAL FIELD 
The presently-disclosed subject matter generally relates to 
substituted phenothiazine derivatives that contain substitu-
ents at the 1,10 position or at the 1,9,10 position that raise 
oxidation potentials regardless of whether the substituent is 
electron-donating or electron withdrawing, without neces-
sarily concomitantly raising reduction potentials. 
INTRODUCTION 
The redox potentials of it-conjugated organic molecules 
and polymers are important factors that determine, in part, 
their performance in organic electronic devices and in 
energy collection and storage applications. In these systems, 
the general prescriptions to control redox potentials involve 
substitution with electron-donating and/or electron-with-
drawing groups, making use of the well-known Hammett 
constants as predictors of the extent of the change of redox 
potentials, [IJ and/or modifying the length of the it-conjuga-
tion pathway, e.g. going from ethylene to butadiene to 
hexatriene and beyond. 
2 
overcharge protection has been demonstrated for lower-
voltage LiFePO4 cathodes,[
3a.9 J which require shuttles that 
oxidize at potentials of 3.8 to 3.9 V vs. Li+m_ However, the 
protection of higher-voltage cathodes (i.e. LiCoO2 , 
5 LiMnO2 , and LiNi113Mn113Co 113O2 ) require oxidation 
potentials of 4.2 V or higher, and no shuttle has provided 
extensive protection in cells containing graphitic anodes. 
Maximizing both the energy density and the durability of 
a LIBs requires charging to a precise voltage: below that 
10 
potential, the full capacity of the cell is not utilized; at higher 
potentials, a cell enters overcharge, a condition that can 
seriously degrade LIBs and lead to hazardous operating 
conditions. [3l 
The road to higher oxidation potential shuttles via the 
incorporation of strong electron-withdrawing groups on 
15 viable low-voltage shuttles can introduce perils in the frame-
work of LIB s. Electron-withdrawing substituents shift both 
the oxidation and reduction potentials to more positive 
values, producing compounds that are more susceptible to 
decomposition through subsequent reactions after reduction 
20 to the radical anion at the anode_E?a.rnJ Premature failure of 
phenothiazine redox shuttles containing chlorine, bromine, 
cyano, or nitro groups can be traced back to having reduc-
tion potentials >O V vs. Li+/0[7 a.10eJ Dimethoxybenzene 
derivatives containing strongly electron-withdrawing 
25 groups have short-lived performance in overcharge when 
incorporated into lithium-ion cells containing graphite 
anodes, [IOa-dJ perhaps as a result of reductive decomposition 
at the anode/electrolyte interface. This is supported by 
reports of the redox shuttle 1,4-di-tert-butyl-2,5-bis(2,2,2-
30 trifluoroethoxy)benzene surviving 2x longer in a cells con-
taining the Li4 Ti5O12 anode when compared to LIBs with 
either the highly reducing graphitic or lithium metal 
anodes. [IObJ 
As such, the incorporation of strongly electron-withdraw-
ing groups is a problematic route for molecules that require 
35 stability at both high and low redox potentials. Thus, a new 
approach for designing stable, high-voltage redox shuttles is 
needed. 
Another route to modify molecular redox potentials 
exploits strain-induced disruptions of the it-conjugated 40 
framework) Such chemical modifications typically use so-
called bulky substituents to manipulate the dihedral torsions 
among the it-conjugated moieties that make up the molecu-
SUMMARY 
In some embodiments of the subject matter, the phenothi-
azine derivatives presently disclosed can be used in 
rechargeable batteries to confer overcharge protection in 
such batteries. In particular, certain embodiments of the 
lar systems. Prime examples include biphenyl (or more 
generally oligo- or polyphenylenes), where substituents 45 
incorporated at the 2, 2', 6, and/or 6' positions increase the 
twist angle between the phenyl groups, and oligothiophenes, 
where similar tactics are employed with substituents placed 
at the 3 and/or 4 positions) Notably, these considerations 
have been widely used in the development of it-conjugated 50 
polymers for electronics and solar cell applications. 
presently-disclosed subject matter relate to conferring over-
charge protection in lithium-ion batteries and/or lithium-air 
batteries and/or redox flow batteries. 
In some embodiments of the subject matter, the phenothi-
azine derivatives can be used as photo-redox catalysts, 
photoinitiators, redox mediators in electrochemical surface 
patterning, and in other applications. 
Embodiments of compounds disclosed herein are substan-
tially more planar in their radical-cation states as compared 
to their neutral states. Embodiments of compounds disclosed 
herein have increased oxidation potentials without requiring 
Strain has also been used to instill curvature into it-con-
jugated networks to alter optical and/or redox characteris-
tics, for example in fullerenes,[4 l cyclized stilbenes,E5l and 
twisted acenes ( so-called 'twistacenes '). [6l In each of these 
latter examples, the it-conjugated networks are strained in 
both the ground (neutral) and ionized ( oxidized or reduced) 
electronic states. 
55 
use of electron-withdrawing groups, leading to less-easily 
accessed reduction potentials. 
Molecular redox shuttles can be used to mitigate excess 
current in overcharging batteries by spatially ferrying charge 60 
through a series of electron-transfer reactions, oxidizing to 
their radical-cation form at the cathode and reducing to their 
neutral form at the anode. For molecules designed to miti-
gate overcharge in LIBs, chemical substitutions are made to 
adjust the oxidation potentials with respect to the reduction 65 
potential of the cathode to ensure that the shuttles become 
redox active just after a cell is fully charged. [3l Extensive 
In some embodiments, the phenothiazine compound is 
provided according to the formula: 
US 10,854,911 B2 
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In some embodiments of the formula, R1 and R9 are 
independently selected from the group consisting of H, 
alkyl, aryl, perfluoroaryl, perfluoroalkyl, alkylaryl, alkox-
yaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, perfluoro-
alkyl, glycols, haloaryl, a negative electrolyte, and a poly- 5 
mer, so long as when R1 is H, R9 is not H. In some 
embodiments, R3 and R7 are independently selected from the 
group consisting of H, alkyl, perfluoroalkyl, alkylaryl, 
alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, perfluo-
roalkyl, glycols, haloaryl, a negative electrolyte, and a 10 
polymer. The term negative electrolyte is well understood to 
those of ordinary skill in the art. In some embodiments, R10 
is selected from the group consisting of methyl, alkyl, aryl, 
alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, 
15 
haloalkyl, perfluoroalkyl, perfluoroaryl, glycols, haloaryl, an 
oligomer, and a polymer. 
4 
(V) 
In some embodiments, the compound has the structure of 
formula VI. 
CH3y CH3 AvN+ 
USN 
(VI) 
As will be recognized by those of ordinary skill in the art, 
examples of negative electrolytes include, but are not lim-
ited to, quinones, pyridines, pyrenes, nictotinamides, qui-
20 
noxaline compounds, dipyridyl ketone compounds, and 
viologen compounds, among other electrochemically reduc-
ible conjugated organic molecules. The term polymer is also 
well understood to those of ordinary skill in the art. As will In some embodiments, the compound has the structure of 
25 formula VII. be recognized by those of ordinary skill in the art, examples 
of polymers that can be used in accordance with the pres-
ently-disclosed subject matter include, but are not limited to, 
oligoglycols and polyethylene glycols, polyacrylates, poly-




In some embodiments, the compound has the structure of 
formula II. 
(II) 35 
In some embodiments, the compound has the structure of 
formula III. 
In some embodiments, the compound has the structure of 
formula IV. 
(IV) 
In some embodiments, the compound has the structure of 
formula V. 
In some embodiments, the compound has the structure of 
40 formula VIII. 
(VIII) 
45 
BRIEF DESCRIPTION OF THE DRAWINGS 
55 
The novel features of the invention are set forth with 
particularity in the appended claims. A better understanding 
of the features and advantages of the present invention will 
be obtained by reference to the following detailed descrip-
tion that sets forth illustrative embodiments, in which the 
60 
principles of the invention are used, and the accompanying 
drawings of which: 
FIG. 1 depicts the structures of various phenothiazine 
derivatives. 
FIG. 2 includes representations of the potential energy 
65 surfaces for the oxidation of EPT, 3,7-DMeEPT, and 1,9-
DMeEPT. The gray arrow with a dotted line depicts the 
vertical ionization process from ground-state, neutral spe-
US 10,854,911 B2 
5 
cies. Shaded regions represent relaxation energies in the 
radical-cation potential energy surfaces. The change in IP is 
given by MP. 
FIG. 3 shows cyclic voltammograms of EPT, 3,7-
DMeEPT, 1,9-DMeEPT, 1,9-DMeiPrPT, and 1,9-DMePhPT 5 
at 1.6mMin0.1 MnBu4 NPF6 in DCM. Voltammograms are 
calibrated to Cp2Fe+
10 at O V, and recorded at 100 mV/s. 
FIG. 4 includes cyclic voltammograms of EPT, 3,7-
DMeEPT, 1,9-DMeEPT, 1,9-DMeiPrPT, and 1,9-DMePhPT 
at 1.6 mM in 0.1 M nBu4 NPF 6 in DCM vs. Cp2 Fe+io at O V, 10 
recorded at scan rates of 100 mV/s. 
FIGS. Sa and Sb are UV-vis absorption spectra of EPT, 
3,7-DMeEPT, 1,9-DMeEPT, 1,9-DMeiPrPT, and 1,9-
DMePhPT in their neutral (a) and radical cation (b) forms at 
14 µM and 0.1 mM, respectively, in DCM. Note: No 15 
spectrum is reported for the 1,9-DMePhPT radical cation 
due to its irreversible first oxidation event. 
FIG. 6 depicts minimized structures and butterfly angles 
for the neutral (top) and radical cation (bottom) states of 
1,9-DMeiPrPT and 1,9-DMePhPT obtained from DFT cal- 20 
culations at the B3LYP/6-311G(d,p) level of theory. 
6 
(LIBs). As detailed herein, the present inventors have dem-
onstrated molecular design principles to dictate the relax-
ation processes of it-conjugated molecules through strain 
solely in their ionized state, while imparting minimal change 
to the ground-state characteristics, as an effective way to 
synthetically control redox potentials. 
Some embodiments of the presently-disclosed subject 




FIG. 7 includes a thermal ellipsoid plot for the 1,9-
DMeEPT molecule. 
FIG. 8 includes a thermal ellipsoid plot for the 1,9-
DMeiPrPT molecule. 
FIG. 9 includes a thermal ellipsoid plot for one molecule 
of 1,9-DMePhPT. This structure contained four chemically 
equivalent but crystallographically independent molecules. 
R1 and R9 are independently selected from the group 
consisting of H, alkyl, aryl, perfluoroaryl, perfluoroalkyl, 
alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, 
25 haloalkyl, perfluoroalkyl, glycols, haloaryl, a negative elec-
trolyte, and a polymer, so long as when R1 is H, ~ is not H; 
FIG. 10 includes a thermal ellipsoid plot for one molecule 
of N-ethyl-1,9-dimethyl-3, 7-bis(trifluoromethyl)phenothi-
azme. 
R3 and R7 are independently selected from the group 
consisting of H, alkyl, perfluoroalkyl, alkylaryl, alkoxyaryl, 
alkylcarboxyl, aryl carbonyl, haloalkyl, perfluoroalkyl, gly-
30 cols, haloaryl, a negative electrolyte, and a polymer; and 
FIG. 11 includes cyclic voltammograms of EPT, 3,7-
DMeEPT, 1,9-DMeEPT, 1,9-DMeiPrPT, and 1,9-DMePhPT 
at 1.6 mM in 0.1 M nBu4 NPF 6 in DCM vs. Cp2 Fe+io at O V, 
containing ferrocene or decamethylferrocene as an internal 35 
reference, recorded at scan rates of 100 mV/s. 
R10 is selected from the group consisting of methyl, alkyl, 
aryl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl carbonyl, 
haloalkyl, perfluoroalkyl, perfluoroaryl, glycols, haloaryl, an 
oligomer, and a polymer. 
In some embodiments of the compound, R1 and R9 are 
each CH3 or CFy In some embodiments of the compound, 
R1 and R9 are each CH3 . In some embodiments of the 
compound, R1 and R9 are aryl and perfluoroaryl. In some 
FIGS.12a-12e are 1H and 13C NMR spectra of the neutral 
compounds of (a) Bis(o-tolyl)amine, (b) 1,9-DMePT, (c) 
1,9-DMeEPT, (d) 1,9-DMeiPrPT, and (e) 1,9-DMePhPT. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
40 embodiments of the compound, R10 is H, alkyl, or aryl. In 
some embodiments of the compound, R10 is methyl, ethyl, 
isopropyl, phenyl, aryl, or perfluoroaryl. 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this document. 45 
Modifications to embodiments described in this document, 
and other embodiments, will be evident to those of ordinary 
skill in the art after a study of the information provided in 
this document. The information provided in this document, 
and particularly the specific details of the described exem- 50 
plary embodiments, is provided primarily for clearness of 
understanding and no unnecessary limitations are to be 
understood therefrom. In case of conflict, the specification of 
this document, including definitions, will control. 
The presently-disclosed subject matter includes recharge- 55 
able batteries and compounds for use in such batteries. 
Compounds disclosed herein are useful for conferring over-
charge protection, for example. Compounds disclosed 
herein also include those which are substantially more 
planar in their radical-cation states as compared to their 60 
neutral states, and which have increased oxidation potentials 
without requiring use of electron-withdrawing groups, lead-
ing to less-easily accessed reduction potentials. 
The possibility of raising phenothiazine oxidation poten-
tials without incorporating electron-withdrawing groups was 65 
explored by the present inventors in connection with their 
work on overcharge protection of lithium-ion batteries 
In some embodiments, the compound has the structure of 
formula II. 
(II) 
In some embodiments, the compound has the structure of 
formula III. 
(II) 
US 10,854,911 B2 
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In some embodiments, the compound has the structure of 
formula IV. 
8 
substituents. These symbols can be any sub stituent, not 
limited to those disclosed herein, and when they are defined 
to be certain substituents in one instance, they can, m 
another instance, be defined as some other substituents. 
(IV) 5 The term "alkyl" as used herein is a branched or 
In some embodiments, the compound has the structure of 
formula V. 
(V) 
In some embodiments, the compound has the structure of 
formula VI. 
unbranched saturated hydrocarbon group of 1 to 24 carbon 
atoms, such as methyl, ethyl, n-propyl, isopropyl, n-butyl, 
isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neo-
pentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetrade-
10 cyl, hexadecyl, eicosyl, tetracosyl, and the like. The alkyl 
group can be cyclic or acyclic. The alkyl group can be 
branched or unbranched. The alkyl group can also be 
substituted or unsubstituted. For example, the alkyl group 
can be substituted with one or more groups including, but 
15 not limited to, optionally substituted alkyl, cycloalkyl, 
alkoxy, amino, ether, halide, hydroxy, nitro, silyl, sulfo-oxo, 
or thiol, as described herein. A "lower alkyl" group is an 
alkyl group containing from one to six (e.g., from one to 
20 
four) carbon atoms. 
Throughout the specification "alkyl" is generally used to 
refer to both unsubstituted alkyl groups and substituted alkyl 
groups; however, substituted alkyl groups are also specifi-
cally referred to herein by identifying the specific 
substituent(s) on the alkyl group. For example, the term 
25 "halogenated alkyl" specifically refers to an alkyl group that 
is substituted with one or more halide, e.g., fluorine, chlo-
rine, bromine, or iodine. The term "alkoxyalkyl" specifically 
refers to an alkyl group that is substituted with one or more 
(VI) 30 
alkoxy groups, as described below. The term "alkylamino" 
specifically refers to an alkyl group that is substituted with 
one or more amino groups, as described below, and the like. CH3y CH3 ),_N+ 
USN 
In some embodiments, the compound has the structure of 
formula VII. 
CH;9 CH; ),_N+ 
USN 
(VII) 
In some embodiments, the compound has the structure of 
formula VIII. 
(VIII) 
In defining various terms such as "R", such terms are used 
herein as generic symbols to represent various specific 
When "alkyl" is used in one instance and a specific term 
such as "alkylalcohol" is used in another, it is not meant to 
imply that the term "alkyl" does not also refer to specific 
35 terms such as "alkylalcohol" and the like. 
This practice is also used for other groups described 
herein. That is, while a term such as "cycloalkyl" refers to 
both unsubstituted and substituted cycloalkyl moieties, the 
substituted moieties can, in addition, be specifically identi-
40 fled herein; for example, a particular substituted cycloalkyl 
can be referred to as, e.g., an "alkylcycloalkyl." Similarly, a 
substituted alkoxy can be specifically referred to as, e.g., a 
"halogenated alkoxy," a particular substituted alkenyl can 
be, e.g., an "alkenylalcohol," and the like. Again, the prac-
45 tice of using a general term, such as "cycloalkyl," and a 
specific term, such as "alkylcycloalkyl," is not meant to 
imply that the general term does not also include the specific 
term. The term "alkyl" is inclusive of "cycloalkyl." 
The term "cycloalkyl" as used herein is a non-aromatic 
50 carbon-based ring composed of at least three carbon atoms. 
Examples of cycloalkyl groups include, but are not limited 
to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, nor-
bornyl, and the like. The term "heterocycloalkyl" is a type 
of cycloalkyl group as defined above, and is included within 
55 the meaning of the term "cycloalkyl," where at least one of 
the carbon atoms of the ring is replaced with a heteroatom 
such as, but not limited to, nitrogen, oxygen, sulfur, or 
phosphorus. The cycloalkyl group and heterocycloalkyl 
group can be substituted or unsubstituted. The cycloalkyl 
60 group and heterocycloalkyl group can be substituted with 
one or more groups including, but not limited to, optionally 
substituted alkyl, cycloalkyl, alkoxy, amino, ether, halide, 
hydroxy, nitro, silyl, sulfo-oxo, or thiol as described herein. 
In this regard, the term "heterocycle," as used herein 
65 refers to single and multi-cyclic aromatic or non-aromatic 
ring systems in which at least one of the ring members is 
other than carbon. Heterocycle includes pyridinde, pyrimi-
US 10,854,911 B2 
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dine, furan, thiophene, pyrrole, isoxazole, isothiazole, pyra-
zole, oxazole, thiazole, imidazole, oxazole, including, 1,2, 
3-oxadiazole, 1,2,5-oxadiazole and 1,3,4-oxadiazole, 
thiadiazole, including, 1,2,3-thiadiazole, 1,2,5-thiadiazole, 
and 1,3,4-thiadiazole, triazole, including, 1,2,3-triazole, 1,3, 
4-triazole, tetrazole, including 1,2,3,4-tetrazole and 1,2,4,5-
tetrazole, pyridine, pyridazine, pyrimidine, pyrazine, triaz-
ine, including 1,2,4-triazine and 1,3,5-triazine, tetrazine, 
including 1,2,4,5-tetrazine, pyrrolidine, piperidine, pipera-
zine, morpholine, azetidine, tetrahydropyran, tetrahydro-
furan, dioxane, and the like. 
The terms "alkoxy" and "alkoxyl" as used herein to refer 
to an alkyl or cycloalkyl group bonded through an ether 
linkage; that is, an "alkoxy" group can be defined as -OA 1 
where A' is alkyl or cycloalkyl as defined above. "Alkoxy" 
also includes polymers of alkoxy groups as just described; 
that is, an alkoxy can be a polyether such as -OA1-OA2 
or---OA1-(OA2 )a-OA3 , where "a" is an integer of from 1 
10 
The term "carboxylic acid" as used herein is represented 
by a formula ----C(O)OH. 
The term "ester" as used herein is represented by a 
formula ---OC(O)A1 or C(O)OA1, where A1 can be an 
5 optionally substituted alkyl, cycloalkyl, alkenyl, cycloalk-
enyl, alkynyl, cycloalkynyl, aryl, or heteroaryl group as 
described herein. The term "polyester" as used herein is 
represented by a formula -(A1O(O)C-A2 -C(O)O)a-
or -(A1O(O)C-A2 -OC(O))a-, where A1 and A2 can be, 
10 independently, an optionally substituted alkyl, cycloalkyl, 
alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, or het-
eroaryl group described herein and "a" is an integer from 1 
to 500. "Polyester" is as the term used to describe a group 
15 
that is produced by the reaction between a compound having 
at least two carboxylic acid groups with a compound having 
at least two hydroxyl groups. 
The term "halide," "halogen," or the like refer to the 
halogens fluorine, chlorine, bromine, and iodine. 
to 200 andA1,A2 , andA3 are alkyl and/orcycloalkyl groups. 20 The term "thiol" as used herein is represented by a 
formula -SH. The term "alkenyl" as used herein is a hydrocarbon group 
of from 2 to 24 carbon atoms with a structural formula 
containing at least one carbon-carbon double bond. The term 
The term "polymer," when used herein to refer to R of the 
compounds disclosed herein, includes vinyl polymers, 
including but not limited to ethylene, propylene, and styryl is include of linear and ring-forming (i.e., cycloakenyl) 
groups. Asymmetric structures such as (A 1 A2)C=C(A3 A 4 ) 
are intended to include both the E and Z isomers. This can 
be presumed in structural formulae herein wherein an asym-
metric alkene is present, or it can be explicitly indicated by 
the bond symbol C=C. The alkenyl group can be substi-
tuted with one or more groups including, but not limited to, 
optionally substituted alkyl, cycloalkyl, alkoxy, alkenyl, 
cycloalkenyl, alkynyl, cycloalkynyl, aryl, heteroaryl, alde-
hyde, amino, carboxylic acid, ester, ether, haide, hydroxy, 
ketone, azide, nitro, silyl, sulfo-oxo, or thiol, as described 
herein. 
25 polymers, cyclic alkenes, including for example norbomene, 
norbornadiene, cyclopentene, and cyclooctatetraene, acry-
lates, amines, epoxies, isocyanates, and the like. Also, as 
used herein, polymer refers to linear polymers as well as 
other arrangements, including for example, dendrimer, star, 
30 and hyper branched polymers. In some embodiments, the 
polymer can include phenothiazine as the sole monomer in 
a repeating polymer. In some embodiments, the polymer can 
include phenothiazine as part of a polymer that contains 
more than one repeat unit, e.g., alternating copolymer or 
35 block copolymer. Oligomer, as used herein to refer to R of 
the compounds disclosed herein, is made up of a discrete 
number of repeat units typically less than about 20, and in 
some embodiments, is about five or less repeat units or 
monomers. 
The term "aryl" as used herein is a group that contains any 
carbon-based aromatic group including, but not limited to, 
benzene, naphthalene, phenyl, biphenyl, phenoxybenzene, 
and the like. The term "aryl" also includes "heteroaryl," 
which is defined as a group that contains an aromatic group 40 
that has at least one heteroatom incorporated within the ring 
of the aromatic group. Examples ofheteroatoms include, but 
are not limited to, nitrogen, oxygen, sulfur, and phosphorus. 
Likewise, the term "non-heteroaryl," which is also included 
in the term "aryl," defines a group that contains an aromatic 45 
group that does not contain a heteroatom. The aryl group can 
be substituted or unsubstituted. The aryl group can be 
substituted with one or more groups including, but not 
limited to, optionally substituted alkyl, cycloalkyl, alkoxy, 
alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, aryl, het- 50 
eroaryl, aldehyde, amino, carboxylic acid, ester, ether, 
halide, hydroxy, ketone, azide, nitro, silyl, sulfo-oxo, or thiol 
as described herein. The term "biaryl" is a specific type of 
aryl group and is included in the definition of "aryl." Biaryl 
refers to two aryl groups that are bound together via a fused 55 
ring structure, as in naphthalene, or are attached via one or 
more carbon-carbon bonds, as in biphenyl. 
In some embodiments, the compound can be used as a 
redox shuttle. 
In some embodiments, the compound can be used as 
passivating electrolyte additives for lithium-ion, sodium-
ion, and other batteries. 
In some embodiments, the compound can be used as a 
photopolymerization initiator or photoredox catalyst. 
In some embodiments, the compound can be used as an 
electrode material in a battery including non-aqueous redox 
flow batteries. 
As used here, the term "redox shuttle" refers to an 
electrochemically reversible compound that can become 
oxidized at a positive electrode of a battery, migrate to a 
negative electrode of the battery, become reduced at the 
negative electrode to reform the unoxidized/less-oxidized 
shuttle species, and migrate back to the positive electrode. A 
redox shuttle can be an electroactive compound, which can 
be heterocyclic. A redox shuttle can protect against over-
charging. 
The presently-disclosed subject matter includes a 
The term "aldehyde" as used herein is represented by a 
formula ----C(O)H. Throughout this specification "C(O)" is a 
short hand notation for a carbonyl group, i.e., C=O. 60 rechargeable battery. In some embodiments, the recharge-
able battery includes a negative electrode, a positive elec-
trode, and an electrolyte that includes a compound as 
disclosed herein. In some embodiments, the positive elec-
The terms "amine" or "amino" as used herein are repre-
sented by a formula NA1A2 A3 , where A 1, A2 , andA3 can be, 
independently, hydrogen or optionally substituted alkyl, 
cycloalkyl, alkenyl, cycloalkenyl, alkynyl, cycloalkynyl, 
aryl, or heteroaryl group as described herein. In specific 65 
embodiments amine refers to any of NH2 , NH(alkyl), 
NH(aryl), N(alkyl)2 , and N(aryl)2 . 
trode is immersed in the electrolyte. In some embodiments, 
the electrolyte further comprises a charge-carrying medium. 
In some embodiments, the electrolyte further includes a 
lithium salt. 
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Batteries connected in series can be particularly vulner-
able to overcharge. The presently-disclosed subject matter is 
inclusive of an array that includes two or more batteries as 
disclosed herein. In some embodiments, the array includes 
In some embodiments, the rechargeable battery is a 
rechargeable lithium-ion battery, which includes a high-
voltage cathode, a negative electrode, an electrolyte com-
prising a charge-carrying medium and a lithium salt, and a 
redox shuttle comprising a compound as disclosed herein. 5 two or more batteries connected in a series. 
The term "electrolyte" is well understood to those of 
ordinary skill in the art and provides a charge-carrying 
pathway between the negative electrode and the positive 
electrode. The electrolyte can include a charge-carrying 
medium and a lithium salt. The electrolyte can also include 10 
a redox shuttle. 
In some embodiments, the battery makes use of a com-
pound/redox shuttle at a concentration of about 0.05-0.1 M. 
While the terms used herein are believed to be well 
understood by those of ordinary skill in the art, certain 
definitions are set forth to facilitate explanation of the 
presently-disclosed subject matter. 
Unless defined otherwise, all technical and scientific 
terms used herein have the same meaning as is commonly 
understood by one of skill in the art to which the invention(s) 
belong. 
All patents, patent applications, published applications In some embodiments, the battery makes use of a com-
pound/redox shuttle having a solubility of about 0.5 M or 
greater. 
The term "negative electrode" is well understood to those 
15 and publications, databases, websites and other published 
materials referred to throughout the entire disclosure herein, 
unless noted otherwise, are incorporated by reference in 
their entirety. of ordinary skill in the art and refers to one of a pair of 
electrodes that, under normal circumstances and when the 
battery/cell is fully charged, has the lowest potential. The 20 
negative electrode that can be used in connection with the 
presently-disclosed subject matter is not particularly limited 
and can be generally selected from those known in the art, 
for example, a graphitic anode. 
The term "positive electrode" is well understood to those 25 
of ordinary skill in the art and refers to one of a pair of 
electrodes that, under typical circumstances, and when the 
battery/cell is fully charged, will have the highest potential 
that it can achieve under normal operation. 
As passivating electrolyte additive is a composition added 30 
that can stabilize the surface of anode, typically by forming 
a passivation film. 
A photopolymerization initiator is a chemical species that 
upon exposure to light (for example, ultraviolet or visible 
spectrum) produces a reactive species that can react with a 35 
composition, and changes the composition in one or more 
properties. An exemplary photopolymerization initiator can, 
for example, upon exposure to light, react with a polymer-
izable composition to generate a cross-linked polymer. 
A photoredox catalyst uses light to facilitate a chemical 40 
reaction by mediating a transfer of electrons between chemi-
cal compounds. The photoinduction of electron transfer of 
the catalysts allows for the activation of substrates that do 
not readily absorb the energy of light by themselves. 
As noted herein, the presently-disclosed subject matter 45 
includes rechargeable batteries in which the positive elec-
trode is a high-voltage cathode. Examples of high-voltage 
cathodes include, but are not limited to LiFePO4 (LFP), 
LiMn2 O4 (LMO), LiCoO2 (LCO), LiNi113Mn113Co113O2 
(NMC), and LiNi0 8Co0 15Al0 050 2 (NCA). A high-voltage 50 
cathode is one that can be said to have an end-of-charge 
potential of about 4.0 V or greater. Such high-voltage 
cathodes benefit from redox shuttles that oxidize at poten-
tials of at least about 4.0, 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, or 4.7 
Where reference is made to a URL or other such identifier 
or address, it understood that such identifiers can change and 
particular information on the internet can come and go, but 
equivalent information can be found by searching the inter-
net. Reference thereto evidences the availability and public 
dissemination of such information. 
As used herein, the abbreviations for any protective 
groups, amino acids and other compounds, are, unless 
indicated otherwise, in accord with their common usage, 
recognized abbreviations, or the IUPAC Nomenclature. 
Although any methods, devices, and materials similar or 
equivalent to those described herein can be used in the 
practice or testing of the presently-disclosed subject matter, 
representative methods, devices, and materials are described 
herein. 
Following long-standing patent law convention, the terms 
"a", "an", and "the" refer to "one or more" when used in this 
application, including the claims. Thus, for example, refer-
ence to "a cell" includes a plurality of such cells, and so 
forth. 
Unless otherwise indicated, all numbers expressing quan-
tities of ingredients, properties such as reaction conditions, 
and so forth used in the specification and claims are to be 
understood as being modified in all instances by the term 
"about". Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this specification and 
claims are approximations that can vary depending upon the 
desired properties sought to be obtained by the presently-
disclosed subject matter. 
As used herein, the term "about," when referring to a 
value or to an amount of mass, weight, time, volume, 
concentration or percentage is meant to encompass varia-
tions of in some embodiments ±20%, in some embodiments 
±10%, in some embodiments ±5%, in some embodiments 
±1 %, in some embodiments ±0.5%, and in some embodi-
ments ±0.1 % from the specified amount, as such variations 
to about 4.8 Vas compared to Li/Li+. 55 are appropriate to perform the disclosed method. 
In some embodiments of the presently-disclosed subject 
matter, the battery makes use of a compound that oxidizes at 
As used herein, ranges can be expressed as from "about" 
one particular value, and/or to "about" another particular 
value. It is also understood that there are a number of values 
disclosed herein, and that each value is also herein disclosed 
as "about" that particular value in addition to the value itself. 
For example, if the value "10" is disclosed, then "about 10" 
is also disclosed. It is also understood that each unit between 
two particular units are also disclosed. For example, if 10 
and 15 are disclosed, then 11, 12, 13, and 14 are also 
a potential of about 3.7 V to about 5.0 V as compared to 
Li/Li+. In some embodiments of the presently-disclosed 
subject matter, the battery makes use of a compound that 60 
oxidizes at a potential of about 4.0 V to about 4.8 V as 
compared to Li/Li+. In some embodiments, the compound 
oxidizes at a potential of about 4.2 V to about 4.5 V. In some 
embodiments, the compound oxidizes at a potential of about 
4.2 V to about 4.3 V. 65 disclosed. 
The presently-disclosed subject matter is further inclusive 
of an article that includes a battery as disclosed herein. 
As used herein, "optional" or "optionally" means that the 
subsequently described event or circumstance does or does 
US 10,854,911 B2 
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not occur and that the description includes instances where 
said event or circumstance occurs and instances where it 
does not. For example, an optionally variant portion means 
that the portion is variant or non-variant. 
14 
At the outset of the investigation, density functional 
theory (DFT) calculations were performed at the B3LYP/6-
311 G( d,p) level to predict molecular geometries in the 
The presently-disclosed subject matter is further illus-
trated by the following specific but non-limiting examples as 
5 neutral and radical-cation states and the adiabatic and ver-
set forth by the present inventors. The following examples 
may include compilations of data that are representative of 
data gathered at various times during the course of devel-
opment and experimentation related to the present invention. 10 
EXAMPLES 
ti cal ionization potentials (IPs) of various substituted phe-
nothiazines. 
The neutral geometries of EPT, 3,7-DMeEPT, and 1,9-
DMeEPT are quite similar, with the butterfly angles showing 
little variation (139-143°). However, as radical cations, EPT 
and 3,7-DMeEPT are significantly more planar(171°) than Example 1 
Inspired by studies of molecular strain, the strategic 
placement of substituents on the phenothiazine core was 
15 1,9-DMeEPT)(157° (Table 1); note that 180° represents a 
fully planar phenothiazine. Similar trends are noted for the 
other 3,7- and 1,9-substituted phenothiazines in the series. 
TABLE 1 
Adiabatic ionization potentials (IP), half-wave first oxidation potentials (Eu2 •
10
) vs. 
Cp2Fe+/O, and neutral and radical cation butterfly angles. 
Butterfly Angles (0 )[a] 
Compound IP (eV)lal El/2 +lo (V)lhl Neutral Radical Cation 
MPT 6.58 0.31 [e] 143.4 (143.7jl''l 165.2 (177.8) 
EPT 6.48 0.27 138.7 (136.8)[dl 171.4 (173.8) 
iPrPT 6.52 o.33[e] 142.6 (137.9)[e] 160.7 
tBuPT 6.67 0.53[e] 134.2 (135.0jlel 148.3 
PhPT 6.34 0.26[e] 149.5 (162.3)[e] 180.0 
3,7-DMeEPT 6.24 0.13[1] 138.8 (149.3)[1] 171.1 
3,7-BCF3EPT 7.06 0.61[1] 139.7 (144.5-152.l)[gl 171.1 (164.5)[gl 
1,9-DMeEPT 6.68 0.55 143.1 (146.5) 156.6 
1,9-BCF3EPT 7.21 141.8 159.0 
1,9-DMeiPrPT 6.76 0.68 132.5 (134.1) 147.5 
1,9-DMePhPT 6.85 0.86[c] 132.4 (134.9) 137.2 
[a]DFT calculations at the B3LYP/6-31 l(d,p) level of theory; X-ray crystallographic values in parentheses. 
[blcy performed with 1.6 mM in O.lM nBu4NPF6/DCM at 100 mV/s. 




[g]Multiple molecules present in asymmetric unit, reference[121. 
investigated for use to tune molecular redox characteristics 
through geometric constraints, with minimal impact of the 
45 
A series of phenothiazine derivatives have been studied, 
where the geometry of the oxidized (radical-cation) state 
tends to be planar, while the neutral ground state is bent. [7 l 
In particular, for N-substituted phenothiazines (FIG. 1, left), 
the present inventors observed a correlation in the degree of 
molecular bending (referred to as the "butterfly angle") of 
substituent electronic effects. Deliberate incorporation of 
substituents around the periphery of the phenothiazine core 
was also tested for ability to disrupt the relaxation of the 
radical-cation state, thereby increasing the oxidation poten-
tial when compared to the unsubstituted system. 
Derivatives of N-substituted phenothiazines where sub-
stituents were incorporated at positions ortho to the nitrogen 
atom (1 and 9 positions) were evaluated for capability to 
prevent planarization of the oxidized species through steric 
interactions with the N-alkyl group. 
The electrochemical characteristics of these derivatives 
were compared to a parent compound with only an N 
50 the radical-cation geometry and the ease of oxidation: From 
ethyl to iso-propyl to tert-butyl (EtPT, iPrPT, tBuPT), the 
increased substituent size led to a larger radical-cation 
butterfly angle and higher-potential oxidation events (Table 
1 ). Importantly, this effect is opposite to what one would 
55 predict based on the Hammett constants of the substituents, 
suggesting that preventing planarization in radical cations 
may raise oxidation potentials, regardless of the substitu-
ent's Hammett constant. 
substituent, and to derivatives where the same substituents 
are incorporated at positions para to the nitrogen atom (3 and 60 
DFT calculations predict 3,7-DMeEPT to have an adia-
batic IP 0.24 eV smaller than EPT, consistent with measured 
oxidation potentials[9 cJ and expectations based on the elec-
tron-donating capability of a methyl group. However, 1,9-
DMeEPThas an IP 0.20 eVlargerthan EPT (Table 1). Thus, 
for the two DMeEPT constitutional isomers, we observe a 
7 positions) so that planarization in the oxidized state 
remains possible and the full electronic effects of the sub-
stituents would be in play. For the sake of clarity, these 
Examples will focus discussion on the N-ethyl derivatives, 
where EPT is the parent, 1,9-DMeEPT the crowded deriva-
tive, and 3,7-DMeEPT the uncrowded analogue (FIG. 1). 
65 difference in IP of 0.44 eV. The IP trends are similar for 
3,7-BCF3EPT and 1,9-BCF3EPT, with 1,9-BCF3EPT hav-
ing a largerIP, though the IP range is smaller (0.15 V). These 
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15 
results showcase the considerable impact that steric crowd-




Similar trends are observed for the vertical IPs (Table 2). 
5 
Notably, the relaxation energy (!,) in the radical-cation 
D 1 _, D2 vertical transition energies, oscillator strengths (f), and electronic 
configurations for select phenothiazine derivatives as determined with 
TDDFT at tbe B3LYP/6-311G(d,p) level oftbeory. 
Radical Cation 
potential energy surface is smaller for 1,9-DMeEPT (at 0.27 
eV) than for EPT and 3,7-DMeEPT (both at 0.40 eV), 
signifying the impact of the methyl groups at the 1 and 9 
positions in limiting radical cation relaxation to a more 
planar configuration. Moreover, the vertical IPs for EPT and 
1,9-DMeEPT are quite similar (differing by 0.07 eV), while 
that of3,7-DMeEPT is much smaller than EPT (by 0.23 eV), 
revealing the differences in the electronic impact of methyl 
substituents in the 1 and 9 vs. 3 and 7 positions. Potential 
energy surfaces displaying these differences in terms of the 
adiabatic and vertical IPs and relaxation energies are repre-
sented in FIG. 2. 
TABLE 2 
Select frontier molecular orbital energies, vertical and 
adiabatic ionization potentials (VIP and AIP, respectively), and 
relaxation energies in the radical-cation potential energy 
surface (}1.,1p) for select phenothiazine derivatives as 













HOMO-! HOMO LUMO AIP VIP 
(eV) (eV) (eV) (eV) (eV) 
-6.30 -5.27 -0.61 6.58 6.87 
-6.26 -5.30 -0.56 6.48 6.88 
-6.23 -5.22 -0.57 6.52 6.77 
-6.20 -5.39 -0.55 6.67 6.93 
-6.24 -5.16 -0.91 6.34 6.68 
-6.12 -5.15 -0.46 6.24 6.65 
-6.94 -5.96 -1.44 7.06 7.49 
-6.14 -5.40 -0.51 6.68 6.95 
-6.83 -5.96 -1.40 7.21 7.52 
-6.35 -5.69 -0.56 6.76 7.25 














S0 _, S 1 vertical transition energies, oscillator strengths (f), and electronic 
configurations for select phenothiazine derivatives as determined with 
TDDFT at tbe B3LYP/6-311G(d,p) level oftbeoa. 
Neutral 
So_, S1 
Compound (nm, eV) f Configuration 
EPT 322 0.0003 HOMO - LUMO (98%) 
(3.85) 
3,7-DMeEPT 322 0.0004 HOMO - LUMO (5%) 
(3.85) HOMO - LUMO + 1 (92%) 
1,9-DMeEPT 310 0.0052 HOMO - LUMO (97%) 
(4.00) 
1,9-DMeiPrPT 287 0.0148 HOMO - LUMO (91%) 
(4.33) 
1,9-DMePhPT 309 0.0327 HOMO - LUMO (98%) 
(4.02) 
D1 _, D2 
Compound (nm, eV) f Configuration 
10 EPT 773 0.0146 HOMO-! - SOMO (98%) 
(1.60) 
3,7-DMeEPT 755 0.0112 HOMO-! - SOMO (98%) 
(1.64) 
1,9-DMeEPT 1024 0.0105 HOMO-! - SOMO (99%) 
(1.21) 
15 1,9-DMeiPrPT 1127 
(1.10) 
0.0098 HOMO-! - SOMO (99%) 
1,9-DMePhPT 1564 0.0275 HOMO-! - SOMO (99%) 
(0.79) 
20 
With computational results in hand that supported our 
hypothesis, 1,9-DMeEPT and related N-iso-propyl (1,9-
DMeiPrPT) and N-phenyl (1,9-DMePhPT) derivatives 
(FIG. 1) were prepared for further study. Solid-state butterfly 
angles show good agreement with DFT calculations (Table 
25 1 ). Importantly, the trends in oxidation potentials from CV 
experiments (FIG. 3) validated our hypothesis and compu-
tational results. Unlike 3,7-DMeEPT, which is more easily 
oxidized than EPT (by 0.13 V), 1,9-DMeEPT is harder to 
oxidize than EPT (by 0.28 V). Moreover, as the size of the 
30 radical-cation butterfly angle within the series of 1,9-dim-
ethyl-substituted phenothiazines, the oxidation potentials 
increase further. Of the three 1,9-dimethyl-substituted 
derivatives, 1,9-DMePhPT has the highest oxidation poten-
tial. Notably, this trend does not follow that of the solely 
35 N-substituted equivalents (iPrPT is harder to oxidize than 
both EPT and PhPT),[7 bJ though within each series of three 
compounds, the oxidation potentials follow the same trends 
as the calculated adiabatic IPs and radical-cation butterfly 
angles. Furthermore, scans of the full electrochemical win-
40 dow (FIG. 4) show that reduction events remain inaccessible 
throughout the series, with solvent reduction occurring 
before a reduction event could be observed. 
UV-vis absorption spectroscopy was used to explore 





45 While the absorption profiles of neutral EPT and 3,7-
DMeEPT are nearly identical, the absorption onsets of the 
1,9-dimethyl-substituted derivatives are slightly blue-shifted 
(FIG. Sa). These changes in energy, although small, are 
consistent with trends in the energy of the S0 ----;,S 1 transition 
energy determined by time-dependent DFT (TD-DFT) cal-
culations (Table 2). UV-vis spectra of the radical cations, 
generated by chemical oxidation, further reflect differences 
in the oxidized species (FIG. Sb). The absorption spectra of 
the radical cations of EPT and 3,7-DMeEPT show profiles 
consistent with the radical cations of several phenothiazine 
derivatives prepared in our laboratory: intense absorption 
features between 500-600 nm and low-energy, low-intensity 
bands between 650-950 nmP6 •13l By contrast, the analo-
gous absorption features for the 1,9-disubstituted derivatives 
occur at lower energies. These trends in transition energies 
are confirmed by TD-DFT calculations (Table 2). Our results 
suggest that variation in placement of methyl groups affects 
the electronic gap between the HOMO-I and HOMO (using 
the nomenclature of the neutral species), which in tum 
influences the D1 ----;,D2 transition of the radical cation that is 
predominately HOMO-] --;,SOMO (singly-occupied 
molecular orbital) in nature. From DFT calculations, the 
US 10,854,911 B2 
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HOMO of EPT and 1,9-DMeEPT are nearly isoenergetic, 
while that of3,7-DMeEPT is energetically destabilized; this 
18 
mmol), urea (0.90 g, 14.9 mmol), sodium tert-butoxide (6.62 
g, 68.9 mmol), and anhydrous dioxane (70 mL). The reac-
tion mixture was sparged with N2 for 15 min. Bis(diben-
zylideneacetone)palladium(0) (0.092 g, 0.15 mmol) and 
tri-tert-butylphosphonium tetrafluoroborate (0.087 g, 0.30 
mmol) were added and after sparging with Na for an 
additional 10 min, the reaction vessel was sealed with a 
PTFE screw cap. The pressure vessel was immersed in an oil 
bath heated to 100° C. and was stirred overnight. The 
reaction mixture was then removed from the oil bath and 
allowed to cool to room temperature. Water was added to the 
reaction mixture, and the product was extracted with ethyl 
acetate, washed with brine, and dried over magnesium 
sulfate (MgSO4). The organic layer was filtered to remove 
solids and was concentrated by rotary evaporation. The 
is consistent with the trends of the computed vertical IPs, 
confirming the validity of a Koopmans' theorem [ 14 l (Janak' s 
theorem[15l in the context of DFT) estimate of the verticals 5 
IP based on the HOMO energies. However, the HOMO-I of 
3,7-DMeEPT and 1,9-DMeEPT are of similar energy and 
energetically destabilized when compared to EPT, revealing 
the comparable electronic impact of the methyl groups on 
the HOMO-I regardless of the methyl group location on the 10 
phenothiazine. The combination of these effects results in a 
smaller HOMO-I to HOMO energy gap for 1,9-DMeEPT, 
which is found here to translate to a smaller first-excited-
state transition energy of the radical cation. 
15 crude product was passed through a short pad of alumina, 
eluting with hexanes to afford the product as a pale yellow 
oil (2.50 g, 84%). 1H NMR (400 MHz, CDC13 ) Ii 7.17 (d, 
J=7.4 Hz, 2H), 7.09 (t, J=7.6 Hz, 2H), 6.97 (d, J=8.0 Hz, 
2H), 6.88 (t, J=7.4 Hz, 2H), 5.11 (s, lH), 2.24 (s, 6H). 13C 
In summary, by positioning traditionally electron-donat-
ing substituents in close proximity to the N substituent, the 
relaxation of the phenothiazine radical-cation state was 
disrupted with increased the oxidation potentials relative to 
their counterparts that are able to fully relax. This approach 
offers a strain-induced modulation of electrochemical prop-
erties orthogonal to conventional tuning by substituent char-
acter. The aim is to identify new organic materials with 
higher oxidation potentials while limiting access to reduc-
tion events by disrupting relaxation pathways in fused-ring 
systems. 
20 NMR (100 MHz, CDC13 ) 5142.0, 130.9, 127.6, 126.9, 
121.5, 118.4, 17.9. 
Example 2 
2-Bromotoluene was purchased from Oakwood Products. 
Urea, bromoethane, 2-bromopropane, tetrabutylammonium 30 
hexafluorophosphate, tris(4-bromophenyl)aminium 
hexachloroantimonate, anhydrous toluene, and anhydrous 
p-dioxane were purchased from Sigma Aldrich. Phenothi-
azine, sodium hydride (60% dispersion in mineral oil), 
bis( dibenzylideneacetone )palladium(0), sodium tert-butox- 35 
ide, sulfur, iodine, o-dichlorobenzene (ODCB), anhydrous 
dichloromethane (DCM), anhydrous tetrahydrofuran, anhy-
drous N,N-dimethylformamide (DMF), and magnesium sul-
fate were obtained fromAcros Organics. Tri-tert-butylphos-
phonium tetrafluoroborate was obtained from Oxchem. 40 
Silica gel and neutral alumina used for colunm chromatog-
raphy were purchased from Silicycle and Sorbent Technolo-
gies, respectively. Ethyl acetate, hexanes, and diethyl ether 
were purchased from VWR. Solvents used for NMR spec-
troscopy were obtained from Cambridge Isotope Laborato- 45 
nes. 
Example 3 
N-Ethylphenothiazine16 and N-ethyl-3,7-dimethylphe- 50 
nothiazine1 7 were prepared as previously reported. 
S, cat. 12 
ODCB 
180° C., 8 h 
1,9-Dimethylphenothiazine (1,9-DMePT) 
This compound was synthesized following a slightly 
modified version of a reported procedure. 19 To an oven-dried 
pressure tube cooled under Na, bis(o-tolyl)amine (2.70 g, 
13.7 mmol), sulfur (1.09 g, 34.2 mmol), iodine (0.0510 g, 
0.402 mmol), and ODCB (2 mL) were added. The pressure 
tube was sealed with a Teflon cap, and the reaction mixture 
was immersed in an oil bath heated to 180° C. for 8 h. After 
removing the reaction flask from the oil bath, the reaction 
mixture was allowed to cool to room temperature. It was 
then diluted with ethyl acetate and water, and the precipitate 
was removed via filtration. The organic layer was separated 
from the aqueous layer and washed with brine. The organic 
layer was then dried over MgSO4 , filtered, and concentrated 
by rotary evaporation. The resulting crude material was 
purified by colunm chromatography over neutral alumina 
using a gradient of hexanes and ethyl acetate to elute the 








1H NMR (400 MHz, CD3 CN) ll 6.94 (d, J=7.7 Hz, 2H), 6.85 
(d, J=7.7 Hz, 2H), 6.76 (t, J=7.5 Hz, 2H), 6.02 (br, lH), 2.25 
(s, 6H). 13C NMR (100 MHz, CD3CN) 5141.2, 130.1, 
125.4, 123.8, 123.3, 118.9, 17.1. Anal. calcd. for C14H13NS 
C, 73.97; H, 5.76; N, 6.16. Found C, 73.67; H, 5.79; N, 6.06. 
Bis( o-tolyl)amine 
This compound was synthesized by modifying a previ-
ously reported procedure.18 To an oven-dried 350 mL pres-
sure vessel were added 2-bromotoluene (3.62 mL, 30.1 
60 
N ~ CXHX) 65 s ~ I 1) NaH, DMF/THF 60° C., 10 min 2) EtBr, 60° C., o/n 




The organic layer was separated from the aqueous layer, 
washed with water and brine, dried over MgSO4 , and 
concentrated by rotary evaporation. The crude material was 
purified by colunm chromatography over silica gel using D~ USN 5 hexanes as the eluent, then crystallized from aqueous etha-nol, yielding the product as a white crystalline solid (0.25 g, 42%). 1H NMR (400 MHz, CD3CN) Ii 7.22 (dd, J=7.9, 0.6 
Hz, 2H), 7.17 (m, 2H), 7.05 (t, J=7.6 Hz, 2H), 3.79 (heptet, 
1=6.4 Hz, lH), 2.51 (s, 6H), 1.00-0.92 (d, 6H). 13C NMR 
10 (100 MHz, CD3CN) Ii 145.2, 138.9, 137.2, 130.0, 126.22, 
126.18, 53.5, 22.5, 19.1. GC-MS: m/z 269 (8%), 226 
(100%). Anal. calcd. for C18H21 NS C, 75.79; H, 7.11; N, 
5.20. Found C, 75.52; H, 7.12; N, 5.18. 
Synthesis of N-ethyl-1,9-dimethylphenothiazine 
(1,9-DMeEPT) 
In an oven-dried 50 mL round-bottomed flask equipped 
with a reflux condenser under a Na atmosphere, 1,9-dim- 15 
ethylphenothiazine (0.542 g, 2.39 mmol) was dissolved in a 
solution of anhydrous DMF (8 mL) and anhydrous THF (8 
mL). Sodium hydride (0.202 g, 60 wt.% in mineral oil, 5.05 
mmol) was added at room temperature, and the reaction was 
stirred for 10 min. Bromoethane (0.90 mL, 12 mmol) was 
added to the reaction mixture, which was then heated to 
reflux in an oil bath set at 90° C. for 12 h. The reaction 
mixture was cooled to room temperature and quenched with 
ice water. The reaction mixture was then extracted with ethyl 
acetate, and the organic layer was washed with brine and 25 
dried over MgSO4 . The organic extracts were filtered and 
concentrated by rotary evaporation. The resulting organic 
residue was purified by silica gel colunm chromatography 
using a gradient of 0-10% ethyl acetate in hexanes as eluent 
CXHX) N ~ 20 s ~ I PhBr, Pd(dba)2 tBu3P•HBF4, NaOtBu toluene, reflux, o/n 
to afford 0.142 g (23%) of a white solid. The purified product 30 
was further crystallized from aqueous ethanol to afford 
white crystals. 1 H NMR ( 400 MHz, CDCl3 ) Ii 7 .07 ( d, J=7 .9 
Hz, 4H), 6.97 (dd, J=8.0, 7.1 Hz, 2H), 3.45 (q, J=7.1 Hz, 
2H), 2.41 (s, 6H), 1.07 (t, J=7.2 Hz, 3H). 13C NMR (100 
MHz, CDCl3 ) Ii 144.6, 134.9, 134.6, 129.7, 125.2, 125.1, 
35 
77.8, 77.7, 77.5, 77.2, 50.0, 18.9, 14.7. GC-MS: m/z 255 
(24%), 226 (100%). Anal. calcd. for C16H17NS C, 75.25; H, 
6.71; N, 5.38. Found C, 74.95; H, 6.73; N, 5.42. 
9 ~N~ 
USN 
1,9-Dimethy 1-N-pheny lphenothiazine 
(1,9-DMePhPT) 
To an oven-dried 15 mL pressure vessel with stir bar, 
1,9-dimethylphenothiazine (0.45 g, 2.0 mmol), bromoben-
zene (1.57 g, 10.0 mmol), and anhydrous toluene (5 mL) 
l)NaH,DMF 
0° C.,5 min 
40 were added, and the resulting solution was sparged with Na 
for 10 min. Sodium tert-butoxide (0.29 g, 3.0 mmol), 
bis( dibenzylideneacetone )palladium(0) (0.028 g, 0.050 
mmol), and tri-tert-butylphosphonium tetrafluoroborate 
2) iPrBr, rt, o/n 
~y~ 
USN 
45 (0.030 g, 0.10 mmol) were added, and the reaction was 
sealed with a PTFE screw cap. The reaction flask was 
immersed in an oil bath heated to 120° C. for 36 h with 
50 
stirring, after which the flask was removed from the oil bath 
and allowed to cool to room temperature. Water was added 
to the reaction mixture, and the product was extracted from 
the aqueous layer with diethyl ether. The combined organic 
extracts were washed with brine, dried over MgSO4 , filtered 
to remove solids, and concentrated by rotary evaporation. 
1,9-Dimethyl-N-iso-propy lphenothiazine 
(1,9-DMeiPrPT) 
55 The crude product was purified by silica gel colunm chro-
matography using 0.5% diethyl ether in cyclohexane to 
afford the desired product as a white solid (153 mg, 25%). 
The product was crystallized using aqueous ethanol to afford To an oven-dried 25 mL round-bottomed flask cooled 
under Na was added 1,9-dimethylphenothiazine (0.50 g, 2.2 
mmol) and anhydrous DMF (5 mL). The solution was 60 
immersed in an ice-water bath, after which sodium hydride 
(0.116 g, 60 wt. % in mineral oil, 4.84 mmol) was added. 
After stirring the suspension for 5 min, 2-bromopropane 
(0.81 g, 6.59 mmol) was added into the reaction mixture. 
The reaction was allowed to warm to room temperature and 65 
was stirred for 12 h. Ice was added to the reaction mixture, 
and the resulting precipitate was dissolved in diethyl ether. 
a white crystalline solid. 1 H NMR ( 400 MHz, CDCl3 ) Ii 7 .39 
(d, J=7.6 Hz, 2H), 7.28 (t, J=3.9 Hz, 3H), 7.17 (dt, J=16.0, 
8.0 Hz, 4H), 6.85 (t, J=7.3 Hz, lH), 6.42 (d, J=8.1 Hz, 2H), 
2.51 (s, 6H). 13C NMR (100 MHz, CDCl3 ) Ii 144.9, 141.3, 
138.0, 137.5, 129.1, 129.0, 126.7, 126.5, 119.6, 113.1, 77.5, 
77.4, 77.2, 76.8, 18.4. GC-MS: m/z 226 (77%), 303 (100%). 
Anal. calcd. for C20H17NS: C, 79.17; H, 5.65; N, 4.62. 
Found C, 79.26; H, 5.62; N, 5.72. 
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SADAB S.25 All structures were solved using SHELXT26 
and refined with SHELXL-2014/7.27 Hydrogen atoms were 
included using the riding-model approximation. Non-hydro-
gen atoms were refined with anisotropic displacement 
5 parameters. Atomic scattering factors were taken from the 
International Tables for Crystallography, vol. C.28 Reference 
is made to FIGS. 7-10. 
Example 6 
10 
Electrochemical Analysis. Cyclic voltammetry (CV) 
experiments were performed with a CH Instruments 600D 
potentiostat using a three-electrode system with glassy car-
bon as the working electrode, freshly anodized Ag/ AgCl as 
N-ethyl-1,9-dimethyl-3, 7-bis(trifluoromethyl)phe-
nothiazine (l,9-DMe-3,7 BCF3EPT) 
15 the reference electrode, and a Pt wire as the counter elec-
trode. Each solution contained 1.6 mM analyte and 0.1 M 
TBAPF 6 in DCM. Voltammograms were recorded at a scan 
rate of 100 mV/s. Oxidation potentials are reported relative 
to ferrocenium/ferrocene )(Cp2 Fe+/O. To calibrate samples, 
20 ferrocene or decamethylferrocene was used as an internal 
reference. 
1,9-DMe-3,7-DBrEPT (1.25 g, 3.03 mmol) and Copper(i) 
iodide (4.61 g, 24.2 mmol) were added in to an oven dried 
100 mL pressure vessel under a Na atmosphere. The pres-
sure vessel was transferred to an argon filled glove box, then 
potassium trifluoroacetate (2.76 g, 18.2 mmol) and cesium 
fluoride (0.99 g 6.50 mmol) were added into the pressure 
vessel and removed it from the glove box. N-Methylpyrro-
lidinone (NMP) (44 mL) and 1,3-Dimethyl-2-imidazolidi-
none (10 mL) were added under Na atmosphere to the 
reaction mixture and purged with Na for 10 min in preheated 
(90° C.) oil bath. Pressure vessel was sealed and increased 30 
the temperature up to 180° C. stirred for 48 h. Reaction 
mixture was cooled to room temperature, diluted with ethyl 
acetate and filtered through celite. Then water was added to 
the filtrate and organic product was extracted with ethyl 
acetate. The combined organic layers were washed with 35 
brine and dried over MgSO4 . The organic extracts were 
filtered and concentrated by rotary evaporation. The result-
ing organic crude was purified by silica gel column chro-
matography using a gradient of 0-2% ethyl acetate in 
hexanes as eluent, yielding the product as a white crystalline 40 
solid (0.6 g, 48%). 1H NMR (400 MHz, DMSO-d6) Ii 
7.58-7.51 (m, 4H), 3.57 (q, J=7.1 Hz, 2H), 2.43 (s, 6H), 0.99 
Voltammograms containing the internal reference---either 
ferrocene or decamethylferrocene-in which the first oxi-
dation event of the phenothiazine derivative was accessed 
25 are shown in FIG. 11. 
(t, J=7.1 Hz, 3H). 19F NMR (400 MHz, Chloroform-d) 
ll-65.39 (s, 6H). GCMS: m/z 391 (23%), 362 (100%), 330 
(8%). Anal. Calcd. for C18H15F6NS: C, 55.24; H, 3.86; F, 45 
29.13; N, 3.58; S, 8.19. Found C, 55.04; H, 4.05; N, 3.60. 
Example 4 
Computational Studies. All density functional theory 50 
(DFT) calculations were performed using the Gaussian09 
(Revision A.02b) software suite.20 Geometry optimizations 
of the neutral and radical-cation states were carried out with 
the B3LYP functional21 •22 and 6-311 G( d,p) basis set. Fre-
quency analyses of all (fully relaxed) optimized geometries 55 
were performed to ensure that the geometries were energetic 
minima. Reference is made to FIG. 6. 
Example 5 
60 
X-Ray Crystallography. X-ray diffraction data were col-
lected on either a Nonius kappaCCD diffractometer (MoKD 
X-rays: 1,9-DMeiPrPT) or a Bruker-Nonius XS Proteum 
diffractometer (CuKD X-rays: 1,9-DMeEPT, 1,9-
DMePhPT). Raw data were integrated using the Denzo- 65 
SMN package23 (kappaCCD) or by APEX2 (XS Proteum).24 
Scaling and merging for all datasets were performed using 
Voltammograms of the phenothiazines (note: no internal 
reference in these scans) are shown in FIG. 4 in which the 
full solvent window was scanned. 
Example 7 
UV-Visible Spectroscopy. UV-vis spectra were obtained 
using optical glass cuvettes (Starna) with 1 cm path length 
on an Agilent 8453 diode array spectrophotometer. Spectra 
of neutral compounds were obtained in DCM at concentra-
tions of 14 µM. Spectra of radical cations were obtained in 
anhydrous DCM by mixing 0.5 mL of a 0.5 mM solution of 
TBPASbCl6 in DCM with 2.0 mL of a solution that was 2.5 
mM radical cation. The resultant solution contained 0.1 mM 
radical cation and 1.9 mM neutral analyte. After the cuvette 
was capped and mixed, UV-vis spectra were recorded imme-
diately. 
All publications, patents, and patent applications men-
tioned in this specification are herein incorporated by ref-
erence to the same extent as if each individual publication, 
patent, or patent application was specifically and individu-
ally indicated to be incorporated by reference, including the 
references set forth in the following list: 
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It will be understood that various details of the presently 
disclosed subject matter can be changed without departing 
from the scope of the subject matter disclosed herein. 
Furthermore, the foregoing description is for the purpose of 
illustration only, and not for the purpose of limitation. 
We claim: 
1. A compound according to the formula: 
wherein 
R1 and R9 are independently selected from the group 
consisting of H, alkyl, aryl, perfluoroaryl, perfluo-
roalkyl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl 
carbonyl, haloalkyl, perfluoroalkyl, glycols, 
haloaryl, a negative electrolyte, and a polymer, so 
long as when R1 is H, R9 is not H; 
R3 and R7 are independently selected from the group 
consisting of H, alkyl, perfluoroalkyl, alkylaryl, 
US 10,854,911 B2 
25 
alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, 
perfluoroalkyl, glycols, haloaryl, a negative electro-
lyte, and a polymer; and 
or 
26 
a compound according to the formula: 
R10 is selected from the group consisting of aryl, 5 
alkylaryl, alkoxyaryl, aryl carbonyl perfluoroaryl, 
glycols, haloaryl, an oligomer, and a polymer. 
2. The compound according to claim 1, selected from the 
group consisting of: 
and 







R1 and R9 are independently selected from the group 
consisting of alkyl, aryl, perfluoroaryl, perfluoro-
alkyl, alkylaryl, alkoxyaryl, alkylcarboxyl, aryl car-
bonyl, haloalkyl, perfluoroalkyl, glycols, haloaryl, a 
negative electrolyte, and a polymer; 
R3 and R7 are independently selected from the group 
consisting of H, alkyl, perfluoroalkyl, alkylaryl, 
alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, 
perfluoroalkyl, glycols, haloaryl, a negative electro-
lyte, and a polymer; and 
R10 is selected from the group consisting of aryl, 
alkylaryl, alkoxyaryl, aryl carbonyl, perfluoroaryl, 
haloaryl, an oligomer, and a polymer. 
6. A rechargeable battery comprising: 
a negative electrode; 
a positive electrode; and 
30 
4. The compound according to claim 1, wherein R10 is 
an electrolyte comprising the compound of claim 5. 
7. The battery of claim 6, wherein the positive electrode 
is immersed in the electrolyte. 
phenyl. 
5. A compound according to the formula: 
wherein R1 and R9 are each CH3 or CF3 , 
35 
8. The battery of claim 6, wherein the electrolyte further 
comprises a charge-carrying medium and a lithium salt. 
9. The battery of claim 6, wherein the positive electrode 
comprises a high-voltage cathode. 
10. The battery of claim 9, wherein the high-voltage 
cathode is selected from LiFePO4 (LFP), LiMn2 O4 (LMO), 
LiCoO2 (LCO), LiNi113Mn113Co 113O2 (NMC), and 
40 LiNi0 _8Co0 _15Al0 _05OiNCA). 
11. The battery of claim 10, wherein the negative elec-
trode is a graphitic anode. 
12. A rechargeable battery comprising: 
R3 and R7 are independently selected from the group 45 
consisting of H, alkyl, perfluoroalkyl, alkylaryl, 
alkoxyaryl, alkylcarboxyl, aryl carbonyl, haloalkyl, 
perfluoroalkyl, glycols, haloaryl, a negative electro-
lyte, and a polymer; and 
a negative electrode; 
a positive electrode; 
an electrolyte comprising a charge-carrying medium; and 
a redox shuttle comprising the compound of claim 5. 
13. A battery comprising a passivating electrolyte addi-
R10 is selected from the group consisting of aryl, 
alkylaryl, alkoxyaryl, aryl carbonyl, perfluoroaryl, 
haloaryl, an oligomer, and a polymer; 
a compound selected from the group consisting of: 
CH; Q CH; 
CCNX) I , and s # 
50 tive, wherein the passivating electrolyte additive comprises 
the compound of claim 5. 
55 
14. The battery of claim 13, wherein the battery is selected 
from the group consisting of a lithium-ion battery, a lithium-
air battery, and a sodium-ion battery. 
15. A battery comprising a photopolymerization initiator 
or photoredox catalyst, wherein the photopolymerization 
initiator or photoredox catalyst comprises the compound of 
claim 5. 
60 
16. A battery comprising an electrode material, wherein 
the electrode material comprises the compound of claim 5. 
17. The battery of claim 16, wherein the battery is a 
non-aqueous redox flow battery. 
18. An array comprising two or more of the battery of 
65 claim 6. 
19. The array of claim 18, wherein the two or more battery 
are connected in a series. 
US 10,854,911 B2 
27 
20. A rechargeable battery comprising: 
a negative electrode; 
a positive electrode; and 
an electrolyte comprising the compound of claim 1. 
21. A rechargeable battery comprising: 
a negative electrode; 
a positive electrode; 
an electrolyte comprising a charge-carrying medium; and 
a redox shuttle comprising the compound of claim 1. 
* * * * * 
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